GODREJIND2026-01-012026-03-31GODREJIND2026-03-31GODREJIND2025-03-31GODREJIND2025-04-012026-03-31GODREJIND2026-01-012026-03-31in-capmkt:OtherExpenses1MemberGODREJIND2025-04-012026-03-31in-capmkt:OtherExpenses1MemberGODREJIND2026-03-31OtherNoncurrentFinancialAssetsDomain1GODREJIND2026-03-31OtherNoncurrentAssetsDomain1GODREJIND2026-03-31OtherNoncurrentAssetsDomain2GODREJIND2026-03-31OtherCurrentFinancialAssetsDomain1GODREJIND2026-03-31OtherCurrentFinancialAssetsDomain2GODREJIND2026-03-31OtherCurrentAssetsDomain1GODREJIND2026-03-31OtherCurrentAssetsDomain2GODREJIND2026-03-31OtherNoncurrentFinancialLiabilitiesDomain1GODREJIND2026-03-31OtherNoncurrentFinancialLiabilitiesDomain2GODREJIND2026-03-31OtherNoncurrentLiabilitiesDomain1GODREJIND2026-03-31OtherCurrentFinancialLiabilitiesDomain1GODREJIND2026-03-31OtherCurrentFinancialLiabilitiesDomain2GODREJIND2026-03-31OtherCurrentLiabilitiesDomain1GODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2025-04-012026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2026-03-31in-capmkt:ReportableSegments1MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2026-03-31in-capmkt:ReportableSegments2MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2026-03-31in-capmkt:ReportableSegments3MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2026-03-31in-capmkt:ReportableSegments4MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2026-03-31in-capmkt:ReportableSegments5MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2026-03-31in-capmkt:ReportableSegments6MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2026-03-31in-capmkt:ReportableSegments7MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2026-03-31in-capmkt:ReportableSegments8MemberGODREJIND2026-01-012026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2026-03-31in-capmkt:ReportableSegments9MemberGODREJIND2026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1GODREJIND2025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1GODREJIND2026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss1GODREJIND2025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss1GODREJIND2026-01-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500164GODREJINDNOTLISTEDINE233A01035Godrej Industries LimitedMain BoardEquity2025-04-012026-03-312026-05-152026-05-08INRCroresQuarterlyFourth quarterMulti segment2026-05-1516:00:002026-05-1516:40:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated769372000005806300000827435000001051502000001870500000-5977200000047847000006837000000140970000013236200000735163000009227200000-204000009206800000264280000020470000028475000000635930000000020499000008409200000118470000095939000004442800000396640000056368000003957100000336800000113.1913.190013.1913.190.0220.02730.02811. The above Statement of audited financial results which are published in accordance with Regulation 33 and 52 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, have been reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on May 15, 2026. The financial results are in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under section 133 of the Companies Act, 2013 read with the relevant rules thereunder. The above results have been audited by the Statutory Auditors of the Company who have expressed an unmodified opinion vide their audit reports thereon. <BR> <BR> 2. During the year ended March 31, 2026, the Company has issued 52,753 equity shares of Re. 1 each to eligible employees of the Company against the exercise of options given under Employees Stock Grant Scheme for an aggregate value of Rs. 0.0053 crore. <BR> <BR> 3. During the year ended March 31, 2026, under the Employee Stock Grant Scheme, the Company has granted 36,544 stock grants to eligible employees of the Company. Upon vesting, as per the Scheme, equivalent number of equity shares of nominal value of Re. 1 each in the Company shall be issued to the eligible employees on exercising their grants. <BR> <BR> 4. On November 21, 2025 the Government of India notified four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 , and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Company/Group has assessed and disclosed the incremental impact of these changes basis actuarial valuation and management estimates and have accounted an additional gratuity and leave benefits liability of Rs. 65.81 crore and Rs. 8.21 crore in the Consolidated and Standalone Financial results respectively for the year ended March 31, 2026, as an Exceptional item. After the balance sheet date, while the Central Government notified the final Rules on May 8, 2026, the State Rules are yet to be notified. The company will monitor the developments and update the estimates when state rules are notified. <BR> <BR> 5. The Company has, on January 5, 2026, incorporated a wholly owned subsidiary under the name Godrej Investment Limited, with an investment of Rs. 3,862.70 crores. Subsequently, on January 28, 2026, the Company effected the divestment and transfer of its entire equity holding in Godrej Capital Limited, a subsidiary, to Godrej Investment Limited at a consideration of Rs. 3,862.69 crore. Pursuant to the aforesaid transaction, and with effect from January 28, 2026, Godrej Capital Limited has ceased to be a direct subsidiary of the Company and has become a step-down subsidiary through its holding under Godrej Investment Limited. <BR> <BR> 6. Pursuant to the share purchase agreement with the Promoter Group of Creamline Dairy Products Limited, Godrej Agrovet Limited a subsidiary company has acquired the balance equity stake of 36.79% during the quarter ended June 30, 2025 for Rs. 708.58 crore in Creamline Dairy Products Limited. During the quarter ended September 30, 2025, Godrej Agrovet Limited further acquired 0.46% equity stake for Rs. 8.93 crore thereby increasing the equity stake to 99.78% in Creamline Dairy Products Limited. As at March 31, 2026 Godrej Agrovet Limited is in the process of acquiring the balance 0.22% equity stake. Accordingly, Profit attributable to Non-controlling interest are not comparable to that extent. <BR> <BR> 7. The Board of Directors of Astec LifeSciences Limited (Subsidiary Company of Godrej Agrovet Limited) at its meeting held on June 30, 2025, has inter-alia, approved the Letter of Offer and Rights Issue of 28,01,673 (Twenty Eight Lakh One Thousand Six Hundred and Seventy-Three) fully paid-up Equity Shares of face value of Rs. 10 (Ten) each, for an aggregate amount not exceeding Rs. 249.35 Crore (Rupees Two Hundred and Forty-Nine Crore and ThirtyFive Lakh Only) at the issue price of Rs. 890/- (Rupees Eight Hundred and Ninety Only) per share in the Rights Entitlement ratio of 1 (One) fully paid-up rights equity share for every 7 (Seven) fully paid up equity share, of face value Rs. 10 (Ten) each, held by the eligible equity shareholders of Astec LifeSciences Limited as on Record date, July 04, 2025. The Issue opened on Monday, July 14, 2025 and closed on Monday, July 28, 2025. Other terms of the Issue were included in the Letter of Offer for the Issue. Accordingly, Godrej Agrovet Limited a subsidiary company had participated in the said Rights issue and equity shares have been allotted on July 29, 2025. Consequent to the rights issue, the shareholding % in Astec LifeSciences Limited has increased to 67.03% as at March 31, 2026. Accordingly, Profit attributable to Non-controlling interest are not comparable to that extent. <BR> <BR> 8. During the current year, the managerial remuneration (including commission payable to certain non-executive directors) provided by Godrej Properties Limited, a subsidiary company in relation to certain of its Directors is in excess of the limits laid down under section 197 of the Companies Act, 2013, read with schedule V to the Act. Godrej Properties Limited is in process of obtaining approval for waiver of excess remuneration es per section 197 of the Companies Act, 2013 from Its shareholders at the forthcoming Annual General Meeting. <BR> <BR> 9. Pursuant to SEBI Circular no. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021 read with Circular no. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 dated July 29, 2022, the Company and its subsidiary(ies) have listed Commercial Papers and listed Unsecured Non convertible debentures on concerned Stock Exchange(s). <BR> <BR> 10. Formulae used for Calculation of Key Ratios and Financial indicators: <BR> Debt Equity Ratio (Gross) = Total Debt /Equity <BR> Debt Equity Ratio (Net) = DEBT [Borrowings (excluding Lease Liabilities accounted as per Ind AS 116) - Cash and Bank Balance (includes FD) - Liquid Investments] / Equity <BR> Debt Service Coverage Ratio = EBITDA / [Interest Expense + Repayment of Long Term Borrowings during the period (netted off to the extent of Long term Loans availed during the same period for the repayments)] <BR> Interest Service Coverage Ratio = EBITDA / Interest Expense <BR> EBITDA = Net Profit/(Loss) Before Tax + Interest Expense + Depreciation and Amortisation Expenses+Loss/(Profit) (net) on sale of Property, Plant and Equipment <BR> Current Ratio = Current Assets/Current Liabilities <BR> Long term Debt to Working Capital = Non Current Borrowing / (Current assets-Current Liabilities) <BR> Bad Debts to Accounts Receivable Ratio = Bad Debts/Accounts Receivable <BR> Current Liability Ratio = Current Liabilities /Total Liabilities <BR> Total Debt to Total Assets = (Non Current Borrowing+Current Borrowing)/Total Assets <BR> Debtors Turnover = Revenue from Operations / Average Trade Receivable <BR> Inventory Turnover = (Cost of Materials Consumed + Purchases of Stock in Trade + Changes in Inventories of Finished Goods, Stock in Trade and Work in Progress) / Average Inventory <BR> Operating profit ratio = (Earnings before exceptional item, interest, taxes, depreciation, amortization expenses less Other Income/ Revenue from operations) <BR> Net Profit Margin = Profit/(Loss) for the period/ Revenue from Operations <BR> Net Worth= As defined in sub-section (57) of section 2 of the Companies Act,2013. <BR> 2025-04-012026-03-31AuditedConsolidated222368500000374375000002598060000003000746000007239000000-167011300000187569000002469920000050136000004089420000022966620000030139800000-6581000002948170000054034000004411800000981520000001966650000000044526000002411910000023000000002641910000012405300000117138000001473300000011686100000336800000111142820000036.8336.830036.8336.830.0220.01780.0267Other Expenses13236200000Other Expenses40894200000496583000004058700000432350000010376700000826790000026430000069960000047061900000205463000007391000002142667000001028830000024584040000040361000008805700000383393100000598724300000448636000002009880000030485500000387891000007098210000019289400000224508500000056419800000879652600000001263045700000336800000111428100000111764900000120077500000231842400000214251900000000434630000021859820000013650000006899000000126700000226988900000296127800000111700000007540310000086573100000256007000004083016000003929755000001251500000168580000080421440000010312033000001263045700000other financial assets10288300000Other tax assets (net)6846100000Other non-current assets1959600000Biological Assets707200000Other Financial Assets18582200000Assets classified as held for Sale and Discontinued Operations139400000Other current assets56280400000Lease Liabilities4164700000Other financial liabilities181600000Other non-current liabilities126700000Lease Liabilities1099700000Other financial liabilities24501000000Other current liabilities392975500000Chemicals11020500000Animal Nutrition12698500000Veg Oils3248500000Estate and Property Development39081200000Finance and Investments8854100000Dairy3991900000Crop Care3130900000Hospitality339600000Others2856800000Chemicals41353000000Animal Nutrition49415400000Veg Oils23720400000Estate and Property Development85043300000Finance and Investments32571800000Dairy15890200000Crop Care11883100000Hospitality1196400000Others103091000008522200000027138270000024785000001157670000082743500000259806000000Chemicals401600000Animal Nutrition1322800000Veg Oils141000000Estate and Property Development9468900000Finance and Investments1284100000Dairy16000000Crop Care264800000Hospitality42200000Others260100000Chemicals3066800000Animal Nutrition3505500000Veg Oils3469300000Estate and Property Development28623000000Finance and Investments4609000000Dairy196800000Crop Care1792200000Hospitality178900000Others481900000132015000004592340000029052000001114180000010691000004641800000922720000030139800000Chemicals27451400000Animal Nutrition16291900000Veg Oils10486100000Estate and Property Development816953200000Finance and Investments342159400000Dairy7896200000Crop Care18737500000Hospitality7890800000Others6249100000125411560000089301000001263045700000Chemicals9905600000Animal Nutrition13786800000Veg Oils1620000000Estate and Property Development618181100000Finance and Investments241013700000Dairy3635400000Crop Care9362100000Hospitality7626400000Others2199000000907330100000123873200000103120330000024626800000-152074500000-1094257000000-82449000006000000-26000000259517000000135316500000050136000000000071200000750000089203000001670000004513000000-2556000000008590000000-111777800000-8229610000000062528000000-88548900000000062820000000046590000001028140000000000000000-588500000-37560000000007124000004447500000020700000002022800000-6712500000000000016202300000038137300000987400000744100000348830000000080558700000-59674000000-59674000002882920000022861800000Amount of items that will not be reclassified to profit and loss-57900000-57900000Amount of items that will not be reclassified to profit and loss-76100000-76100000-12300000-16600000Amount of items that will be reclassified to profit and loss12192000001219200000Amount of items that will be reclassified to profit and loss23470000002347000000-11100000-1250000011847000002300000000AuditedtrueKalyaniwalla & Mistrytrue2027-07-31